Folotyn available for peripheral T-cell lymphoma (PTCL)

Folotyn (pralatrexate injection) has been made available by Allos Therapeutics for use as a single agent for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).

Fotolyn is preservative-free and is available in a 20mg/mL dosage strength in 1mL and 2mL vials.

For more information call (303) 426-6262 or visit www.folotyn.com.